RAMM Pharma Corp.
CNQ: RAMM.CN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Canadian Securities Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Jackie Peter Burnett
- Headquarters
- Toronto, Canada
- IPO year
- 2019
- Market cap
- CA$1.2M
- Website
- https://www.rammpharma.com
Loading RAMM…
Loading profile data…Frequently asked questions about RAMM
What does RAMM Pharma Corp. (RAMM.CN) do?
RAMM Pharma Corp. engages in the research and development, production, and sale of cannabinoid pharmaceutical formulations, pharmaceuticals, cosmetics, nutraceutical products, and resale of medical supplies products in Canada and internationally. It offers Epifractán, a cannabinoid pharmaceutical drug; XALEX 10, a prescription pharmaceutical for...
Where does RAMM.CN trade?
RAMM Pharma Corp. (RAMM.CN) trades on the Canadian Securities Exchange.
What sector is RAMM.CN in?
RAMM Pharma Corp. (RAMM.CN) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of RAMM Pharma Corp.?
Jackie Peter Burnett is the chief executive officer of RAMM Pharma Corp. (RAMM.CN).
Where is RAMM Pharma Corp. headquartered?
RAMM Pharma Corp. is headquartered in Canada.
Does RAMM.CN pay a dividend?
RAMM Pharma Corp. (RAMM.CN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did RAMM.CN go public?
RAMM Pharma Corp. (RAMM.CN) completed its initial public offering in 2019.